Etoposide and Celecoxib in Patients With Advanced Cancer
Status:
Completed
Trial end date:
2012-02-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Etoposide and celecoxib may stop the growth of cancer cells by blocking some of
the enzymes needed for cell growth. Giving more than 1 drug may be an effective treatment for
advanced cancer.
PURPOSE: This phase I trial is studying the side effects and best dose of celecoxib when
given together with etoposide in treating patients with advanced cancer.